First Anti-Diabetic Ayurvedic Drug Launched By CSIR

Country’s first anti-diabetic ayurvedic drug with DPP4 inhibitory activity was launched by Council for Scientific and Industrial Research (CSIR).

Named as BGR-34, developed jointly by National Botanical Research Institute (NBRI) and the Central Institute for Medicinal and Aromatic Plants (CIMAP), situated at Lucknow. It is designed for type 2 diabetes mellitus and scientifically validated for its efficacy and safety.

For giving the maximum benefits to people, BGR-34 has been economically priced at Rs 5 per tablet. It is available at all major chemist shops in Chandigarh, Punjab and adjoining states.

According to Dr AKS Rawat, senior principal scientist nearly six crore adult Indian population is found diabetic and there is no effective solution for it till now. It is beneficial for those suffering from type 2 diabetes mellitus for quicker response. However, BGR-34 works by controlling blood sugar and limiting the harmful effects of other drugs unlike the modern diabetic drugs known for side effects and toxicity.

The scientists of the research units of CSIR joined hands for developing an effective, safe medication for managing type 2 diabetes mellitus. Through the in depth study of over 500 renowned ancient herbs they finally identified the list of six best herbs for various ailments and indications such as Daruharidra (Berberisaristata), Giloy (Tinosporacordifolia), Vijaysar (Pterocarpus marsupium), Gudmar (GymnemaSylvestre), Majeeth (Rubiacordifoila) and Methika (Trigonellafoenum-graecum) which are combined in different fractions to develop an amazing anti diabetic medication.

As compared with the reference standard anti-diabetic allopathic drug, the pre-clinical studies of BGR-34 shows the significant reduction in the high blood sugar level.During the course of study, the drug was found to improve LFTs, KFTs and lipid profile and also provides the antioxidant protective activity significantly.

Related Posts

Leave A Comment

Your email address will not be published. Required fields are marked. *